10x Genomics, Inc.
MX ˙ BMV ˙ US88025U1097
SecurityMX:TXG / 10x Genomics, Inc.
InstitutionGeode Capital Management, Llc
Latest Disclosed Ownership2,904,228 shares
Latest Disclosed Value $ 61,669,469
Geode Capital Management, Llc reports 4.10% increase in ownership of TXG / 10x Genomics, Inc.

On May 15, 2026 - Geode Capital Management, Llc filed a 13F-HR form disclosing ownership of 2,904,228 shares of 10x Genomics, Inc. (MX:TXG) valued at $61,669,469 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 2,789,784 shares of 10x Genomics, Inc.. This represents a change in shares of 4.10% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F 10X GENOMICS INC- CL A COM 88025U109 2,904,228 114,444 4.10 61,669 35.51 0.0020
2026-02-09 2025-12-31 13F 10X GENOMICS INC- CL A COM 88025U109 2,789,784 78,541 2.90 45,509 43.57 0.0028
2025-11-12 2025-09-30 13F 10X GENOMICS INC- CL A COM 88025U109 2,711,243 60,424 2.28 31,699 3.25 0.0020
2025-08-08 2025-06-30 13F 10X GENOMICS INC- CL A COM 88025U109 2,650,819 773,203 41.18 30,701 87.24 0.0022
2025-05-13 2025-03-31 13F 10X GENOMICS INC- CL A COM 88025U109 1,877,616 62,793 3.46 16,397 -37.11 0.0013
2025-02-12 2024-12-31 13F 10X GENOMICS INC- CL A COM 88025U109 1,814,823 -887 -0.05 26,069 -36.43 0.0020
2024-11-12 2024-09-30 13F 10X GENOMICS INC- CL A COM 88025U109 1,815,710 42,777 2.41 41,009 18.89 0.0033
2024-08-09 2024-06-30 13F 10X GENOMICS INC- CL A COM 88025U109 1,772,933 129,780 7.90 34,493 -44.08 0.0030
2024-05-13 2024-03-31 13F 10X GENOMICS INC- CL A COM 88025U109 1,643,153 55,338 3.49 61,680 -30.59 0.0057
2024-02-13 2023-12-31 13F 10X GENOMICS INC- CL A COM 88025U109 1,587,815 68,771 4.53 88,869 41.80 0.0093
2023-11-13 2023-09-30 13F 10X GENOMICS INC- CL A COM 88025U109 1,519,044 84,243 5.87 62,672 -21.78 0.0075
2023-08-11 2023-06-30 13F 10X GENOMICS INC- CL A COM 88025U109 1,434,801 68,905 5.04 80,119 5.14 0.0094
2023-05-15 2023-03-31 13F 10X GENOMICS INC- CL A COM 88025U109 1,365,896 44,662 3.38 76,203 158,656.25 0.0099
2023-02-13 2022-12-31 13F 10X GENOMICS INC- CL A COM 88025U109 1,321,234 63,324 5.03 48 -99.87 0.0068
2022-11-14 2022-09-30 13F 10X GENOMICS INC- CL A COM 88025U109 1,257,910 38,393 3.15 35,825 -35.08 0.0054
2022-08-12 2022-06-30 13F 10X GENOMICS INC- CL A COM 88025U109 1,219,517 31,078 2.62 55,183 -38.88 0.0081
2022-05-13 2022-03-31 13F 10X GENOMICS INC- CL A COM 88025U109 1,188,439 28,984 2.50 90,292 -47.66 0.0113
2022-02-11 2021-12-31 13F 10X GENOMICS INC- CL A COM 88025U109 1,159,455 30,714 2.72 172,504 5.11 0.0208
2021-11-12 2021-09-30 13F 10X GENOMICS INC- CL A COM 88025U109 1,128,741 119,254 11.81 164,123 -16.86 0.0221
2021-08-13 2021-06-30 13F 10X GENOMICS INC- CL A COM 88025U109 1,009,487 107,662 11.94 197,409 21.08 0.0272
2021-05-12 2021-03-31 13F 10X GENOMICS INC- CL A COM 88025U109 901,825 113,719 14.43 163,034 46.26 0.0249
2021-02-12 2020-12-31 13F 10X GENOMICS INC- CL A COM 88025U109 788,106 102,357 14.93 111,468 30.37 0.0187
2020-11-13 2020-09-30 13F 10X GENOMICS INC- CL A COM 88025U109 685,749 381,564 125.44 85,498 214.72 0.0168
2020-08-13 2020-06-30 13F 10X GENOMICS INC- CL A COM 88025U109 304,185 198,559 187.98 27,166 312.73 0.0058
2020-05-14 2020-03-31 13F 10X GENOMICS INC- CL A COM 88025U109 105,626 15,754 17.53 6,582 -3.94 0.0017
2020-02-20 2019-12-31 13F/A-1 10X GENOMICS INC- CL A COM 88025U109 89,872 89,872 6,852 0.0014
2020-02-13 2019-12-31 13F 10X GENOMICS INC- CL A COM 88025U109 89,872 6,852 0.0014
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.